Abregen is Biotechnology in Australia that focus on drosophila melanogaster business. Founded in 2008. They cover business area such as developer, therapeutic antibody, regenerative medicine, antibody-base therapeutic, rare, genetic skin disease, epidermolysis bullosa, a fruit fly, (drosophila melanogaster, healthcare professional, chronic wound, injury, cancer, fragile skin disorder.
2008
( 16 years old in 2024 )
Drosophila Melanogaster
-
Future Industries Institute
University of South Australia
Mawson Lakes, South Australia 5095
Australia
Private
developertherapeutic antibodyregenerative medicineantibody-base therapeuticrare, genetic skin diseaseepidermolysis bullosaa fruit fly(drosophila melanogasterhealthcare professionalchronic woundinjurycancerfragile skin disorder
* We use standard office opening hours in near Abregen's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Abregen is Biotechnology business from Australia that founded in 2008 (16 years old in 2024), Abregen business is focusing on Drosophila Melanogaster.
Abregen headquarter office and corporate office address is located in Future Industries Institute University of South Australia Mawson Lakes, South Australia 5095 Australia.
Abregen was founded in Australia.
In 2024, Abregen is currently focus on drosophila melanogaster sector.
Above is snippet of Google Trends for "drosophila melanogaster" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Abregen, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
